News

AliveDx Suisse S.A. is pleased to announce the signing of a strategic distribution agreement with Ilex Medical. Under this agreement, Ilex Medical is authorized to distribute AliveDx’s MosaiQ® and LumiQ® solutions in Israel. This partnership represents another important milestone in AliveDx’s strategy to expand its footprint in key markets and to support healthcare providers with…

AliveDx Suisse S.A. is pleased to announce the signing of a strategic distribution agreement with Hospital Supply Corporation (HSC), Pakistan. Under this agreement, HSC is authorized to distribute AliveDx’s MosaiQ® and LumiQ® solutions across Pakistan.   This partnership represents an important milestone in AliveDx’s expansion in South Asia and reinforces its commitment to working with established local partners to deliver innovative, high-value diagnostic technologies.…

AliveDx Suisse S.A. is pleased to announce the signing of a strategic distribution agreement with Reacting Sarl. Under this agreement, Reacting Sarl is authorized to distribute AliveDx’s MosaiQ® and LumiQ® solutions across Morocco. This partnership represents a further step in AliveDx’s expansion across North Africa and underscores its commitment to working with strong local partners…

AliveDx Suisse S.A. is pleased to announce the signing of a strategic distribution agreement with Address Medical. Under this agreement, Address Medical is authorized to distribute AliveDx’s MosaiQ® and LumiQ® solutions in United Arab Emirates. This partnership represents another important milestone in AliveDx’s strategy to expand its footprint in key emerging markets and to support…

AliveDx Suisse S.A. and DPC Lebanon (Diagnostic Products Corporation Lebanon Sarl) Sign Strategic Distribution Agreement in Lebanon AliveDx Suisse S.A. is pleased to announce the signing of a strategic distribution agreement with DPC Lebanon. Under this agreement, DPC Lebanon is authorized to distribute AliveDx’s MosaiQ® and LumiQ® solutions across Lebanon. This partnership represents an important…

AliveDx is proud to announce that we have successfully completed the 2025/26 NHS Evergreen Sustainable Supplier Assessment, achieving Level 2 status in the UK. This annual assessment is a key benchmark for suppliers to the NHS in the UK, measuring progress toward sustainability and net zero goals. We are pleased to share that our Eysins…

AliveDx Suisse S.A. is pleased to announce the signing of a strategic distribution agreement with Medipac Technologies Ltd, a leading healthcare-solutions provider in Bangladesh. Under this partnership, Medipac Technologies Ltd will distribute AliveDx’s innovative MosaiQ® and LumiQ® diagnostic platforms across Bangladesh, effective immediately.  This collaboration strengthens AliveDx’s commitment to expanding its presence in high-growth emerging markets by delivering advanced diagnostic technologies that are designed to…

Following our recent announcement that AliveDx had been shortlisted, we’re proud to confirm that we’ve now been officially recognised as one of the UK’s Best Workplaces in Biopharma with the list now published in The Guardian. This recognition places AliveDx among the top organisations in the country for workplace culture, innovation and employee wellbeing. The…

We’re proud to announce that AliveDx has been officially recognised as one of the UK’s Best Workplaces in BioPharma™ 2025 by Great Place to Work® UK. This is a prestigious honour that places us among the top 30 biopharma companies in the country. This recognition follows our earlier achievement of becoming Great Place to Work…

AliveDx Suisse S.A. (AliveDx) and Transmedic Indonesia, Thailand and Singapore have signed a second distribution agreement, enabling Transmedic to distribute the LumiQ® solution across these markets. The distribution agreement takes effect immediately. This partnership underscores AliveDx’s dedication to expanding its global footprint and delivering clinical and economic value to clinicians, supporting faster diagnosis. Together, AliveDx…